In the Journal of Clinical Oncology Special Series issue, the ASCO-Friends of Cancer Research working group examines specific eligibility criteria to determine whether to modify definitions to extend clinical trials to a broader population. Criteria examined include:
- Brain metastases
- Minimum age requirements
- HIV/AIDS status
- Organ dysfunction
- Prior and concurrent malignancies
In this issue:
- Broadening Eligibility Criteria to Make Clinical Trials More Representative: American Society of Clinical Oncology and Friends of Cancer Research Joint Research Statement Kim et al
- Re-Evaluating Clinical Trial Eligibility Criteria – Analysis of Investigational New Drug Applications in 2015 Jin et al
- Modernizing Clinical Trial Eligibility Criteria – Recommendations of the ASCO-Friends of Cancer Research HIV Working Group Uldrick et al
- Modernizing Clinical Trial Eligibility Criteria – Recommendations of the ASCO-Friends of Cancer Research Brain Metastases Working Group Lin et al
- Modernizing Clinical Trial Eligibility Criteria – Recommendations of the ASCO-Friends of Cancer Research Organ Dysfunction, Prior or Concurrent Malignancy, and Comorbidities Working Group Lichtman et al
- Modernizing Clinical Trial Eligibility – Recommendations of the ASCO-Friends of Cancer Research Minimum Age Working Group Gore et al